Unichem Laboratories receives ANDA approval for Labetalol Hydrochloride Tablets

Unichem Laboratories Limited has received ANDA approval for its Labetalol Hydrochloride Tablets, USP 100 mg, 200 mg, and 300 mg from the United States Food and Drug Administration (USFDA) to market a generic version of NORMODYNE® (Labetalol Hydrochloride) Tablets 100 mg, 200 mg and 400 mg, of SCHERING CORP SUB SCHERING PLOUGH CORP.

Labetalol Hydrochloride Tablets are indicated for the management of hypertension. The product will be commercialized from Unichem's Goa Plant.

Shares of Unichem Laboratories Limited was last trading in BSE at Rs. 302.95 as compared to the previous close of Rs. 298.55. The total number of shares traded during the day was 10122 in over 1473 trades.

The stock hit an intraday high of Rs. 308.00 and intraday low of 293.50. The net turnover during the day was Rs. 3072110.00.

Source : Equity Bulls

Keywords

UnichemLaboratories INE351A01035 ANDA Approval GenericVersion NORMODYNE